Recent review articles about lung cancer (InTextoResearch)


InTextoResearch, scientific information agency


InTextoResearch informs on the most recent review articles about lung
cancer:

Optimizing chemotherapy for patients with advanced non-small cell lung
cancer.
Scagliotti G.
J Thorac Oncol. 2007 Jun;2 Suppl 2:S86-91.

Current treatment paradigms for locally advanced non-small cell lung
cancer.
Rigas JR, Kelly K.
J Thorac Oncol. 2007 Jun;2 Suppl 2:S77-85.

Weighing tumor biology in treatment decisions for patients with non-
small cell lung cancer.
Shepherd FA, Rosell R.
J Thorac Oncol. 2007 Jun;2 Suppl 2:S68-76.

The importance of accurate lymph node staging in early and locally
advanced non-small cell lung cancer: an update on available
techniques.
Kim ES, Bosquee L.
J Thorac Oncol. 2007 Jun;2 Suppl 2:S59-67.

Interpreting clinical trials in lung cancer: impact of methodology and
endpoints.
Gralla RJ, Griesinger F.
J Thorac Oncol. 2007 Jun;2 Suppl 2:S51-8.

Bronchioloalveolar carcinoma: a review of current concepts and
evolving issues.
Yousem SA, Beasley MB.
Arch Pathol Lab Med. 2007 Jul;131(7):1027-32.

Commonly encountered difficulties in pathologic staging of lung
cancer.
Flieder DB.
Arch Pathol Lab Med. 2007 Jul;131(7):1016-26.

Salvage therapy with vinorelbine in advanced non-small-cell lung
cancer: a retrospective review of the Fox Chase Cancer Center
experience and a review of the literature.
Devlin JG, Langer CJ.
Clin Lung Cancer. 2007 Mar;8(5):319-26.

Surgical management of primary lung cancer.
McKenna RJ Jr.
Semin Oncol. 2007 Jun;34(3):250-5.

Myelolipoma of the lung: a case report and brief review.
Sato K, Ueda Y, Katsuda S, Tsuchihara K.
J Clin Pathol. 2007 Jun;60(6):728-30.

Topotecan for the treatment of small-cell lung cancer.
Nicum SJ, O'Brien ME.
Expert Rev Anticancer Ther. 2007 Jun;7(6):795-801.

Lung cancer: new surgical approaches.
Sherwood JT, Brock MV.
Respirology. 2007 May;12(3):326-32.

Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
Brahmer JR, Ettinger DS.
Respirology. 2007 May;12(3):320-5.

The present status of postoperative adjuvant chemotherapy for
completely resected non-small cell lung cancer.
Tsuboi M, Ohira T, Saji H, Miyajima K, Kajiwara N, Uchida O, Usuda J,
Kato H.
Ann Thorac Cardiovasc Surg. 2007 Apr;13(2):73-7.

miRNA profiling for diagnosis and prognosis of human cancer.
Jay C, Nemunaitis J, Chen P, Fulgham P, Tong AW.
DNA Cell Biol. 2007 May;26(5):293-300.

Docetaxel in non-small cell lung cancer: impact on quality of life and
pharmacoeconomics.
Horn L, Visbal A, Leighl NB.
Drugs Aging. 2007;24(5):411-28.

DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin
to enter clinical trials.
Kratz F.
Expert Opin Investig Drugs. 2007 Jun;16(6):855-66.

Epidermal growth factor receptor mutations in lung cancers.
Yatabe Y, Mitsudomi T.
Pathol Int. 2007 May;57(5):233-44.

Lung cancer in the elderly.
Gridelli C, Langer C, Maione P, Rossi A, Schild SE.
J Clin Oncol. 2007 May 10;25(14):1898-907.

The role of radiotherapy in lung cancer: where is the evidence?
Jassem J.
Radiother Oncol. 2007 May;83(2):203-13.

15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.
Tai HH, Tong M, Ding Y.
Prostaglandins Other Lipid Mediat. 2007 May;83(3):203-8.

Small cell carcinoma of the breast: case report.
Shaco-Levy R, Dyomin V, Kachko L, Sion-Vardy N, Geffen DB, Koretz M.
Eur J Gynaecol Oncol. 2007;28(2):142-4.

Geranylgeranyltransferase I as a target for anti-cancer drugs.
Philips MR, Cox AD.
J Clin Invest. 2007 May;117(5):1223-5.

Small peripheral pulmonary adenocarcinoma: morphologic and molecular
update.
Weydert JA, Cohen MB.
Adv Anat Pathol. 2007 Mar;14(2):120-8.

(contact at InTextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb@xxxxxxxx)

.

Relevant Pages